Ziopharm Oncology TCRT
Ziopharm Oncology: quarterly report for the quarter ended Sep 30, 2020
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001193125-20-286807
- Document
- 10-Q
- Exhibit 10.1
- Material contract
- Exhibit 10.2
- Material contract
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- BioCardia BCDA public float $10M, Jun 30, 2025
- Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
- Traws Pharma ONTX public float $10M, Jun 30, 2025
- Mannatech MTEX public float $10M, Jun 30, 2025
- Bioxytran BIXT public float $9M, Jun 30, 2025
